These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9149472)

  • 1. Digoxin's effect on mortality and hospitalization in heart failure: implications of the DIG study. Digitalis Investigation Group.
    Hobbs RE
    Cleve Clin J Med; 1997 May; 64(5):234-7. PubMed ID: 9149472
    [No Abstract]   [Full Text] [Related]  

  • 2. Whither Withering's Legacy? Digoxin's role in our contemporary pharmacopeia for heart failure.
    Young JB
    J Am Coll Cardiol; 2005 Aug; 46(3):505-7. PubMed ID: 16053965
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutic range of digoxin's efficacy in heart failure: what is the evidence?
    Terra SG; Washam JB; Dunham GD; Gattis WA
    Pharmacotherapy; 1999 Oct; 19(10):1123-6. PubMed ID: 10512061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of oral digoxin in high-risk heart failure patients: a pre-specified subgroup analysis of the DIG trial.
    Gheorghiade M; Patel K; Filippatos G; Anker SD; van Veldhuisen DJ; Cleland JG; Metra M; Aban IB; Greene SJ; Adams KF; McMurray JJ; Ahmed A
    Eur J Heart Fail; 2013 May; 15(5):551-9. PubMed ID: 23355060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of the DIG trial.
    Collins JF; Egan D; Yusuf S; Garg R; Williford WO; Geller N;
    Control Clin Trials; 2003 Dec; 24(6 Suppl):269S-276S. PubMed ID: 14643073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Digoxin Benefit Varies by Risk of Heart Failure Hospitalization: Applying the Tufts MC HF Risk Model.
    Upshaw JN; van Klaveren D; Konstam MA; Kent DM
    Am J Med; 2018 Jun; 131(6):676-683.e2. PubMed ID: 29284111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Digoxin in heart failure.
    Chadwell M; French L
    J Fam Pract; 1997 May; 44(5):442. PubMed ID: 9152256
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial.
    Ahmed A; Rich MW; Fleg JL; Zile MR; Young JB; Kitzman DW; Love TE; Aronow WS; Adams KF; Gheorghiade M
    Circulation; 2006 Aug; 114(5):397-403. PubMed ID: 16864724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whither digitalis?
    Campbell RW
    Lancet; 1997 Jun; 349(9069):1854-5. PubMed ID: 9217753
    [No Abstract]   [Full Text] [Related]  

  • 10. End of the oldest controversy in medicine. Are we ready to conclude the debate on digitalis?
    Packer M
    N Engl J Med; 1997 Feb; 336(8):575-6. PubMed ID: 9023096
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy and safety of digoxin in patients with heart failure and reduced ejection fraction according to diabetes status: An analysis of the Digitalis Investigation Group (DIG) trial.
    Abdul-Rahim AH; MacIsaac RL; Jhund PS; Petrie MC; Lees KR; McMurray JJ;
    Int J Cardiol; 2016 Apr; 209():310-6. PubMed ID: 26913372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of serum digoxin concentration and outcomes in patients with heart failure.
    Rathore SS; Curtis JP; Wang Y; Bristow MR; Krumholz HM
    JAMA; 2003 Feb; 289(7):871-8. PubMed ID: 12588271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Digoxin: the results of the DIG study in the XXI century].
    Helber I; Tucci PJ
    Arq Bras Cardiol; 2010 Oct; 95(4):e108-11. PubMed ID: 21180781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Why are results of studies with digitalis so poor? "It depends on potassium!"].
    Hien M
    MMW Fortschr Med; 2003 Oct; 145(43):21. PubMed ID: 14652934
    [No Abstract]   [Full Text] [Related]  

  • 15. Digoxin in patients with heart failure.
    Umans VA; Cornel JH; Hic C
    N Engl J Med; 1997 Jul; 337(2):129; author reply 130-1. PubMed ID: 9221338
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of digoxin on mortality and morbidity in patients with heart failure.
    Digitalis Investigation Group
    N Engl J Med; 1997 Feb; 336(8):525-33. PubMed ID: 9036306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial.
    Ahmed A; Rich MW; Love TE; Lloyd-Jones DM; Aban IB; Colucci WS; Adams KF; Gheorghiade M
    Eur Heart J; 2006 Jan; 27(2):178-86. PubMed ID: 16339157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digoxin in patients with heart failure.
    Zoneraich S
    N Engl J Med; 1997 Jul; 337(2):130; author reply 130-1. PubMed ID: 9221340
    [No Abstract]   [Full Text] [Related]  

  • 19. Digoxin and 30-day all-cause hospital admission in older patients with chronic diastolic heart failure.
    Hashim T; Elbaz S; Patel K; Morgan CJ; Fonarow GC; Fleg JL; McGwin G; Cutter GR; Allman RM; Prabhu SD; Zile MR; Bourge RC; Ahmed A
    Am J Med; 2014 Feb; 127(2):132-9. PubMed ID: 24067296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Digoxin use in congestive heart failure. Current status.
    Riaz K; Forker AD
    Drugs; 1998 Jun; 55(6):747-58. PubMed ID: 9617590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.